-
November 9: Introduction to Applied Generative AI for HEOR - In Person at ISPOR Europe 2025
-
November 9: Risk-Sharing/Performance-Based Arrangements in Developing Countries - In Person at ISPOR Europe 2025
-
November 9: Health Economic Modeling in R: A Hands-on Introduction - In Person at ISPOR Europe 2025
-
November 9: Advanced Patient-Reported Outcomes - In Person at ISPOR Europe 2025
-
November 9: Reimbursement Systems for Pharmaceuticals in Europe - In Person at ISPOR Europe 2025
-
November 9: Developing Decision-Grade Real-World Evidence - In Person at ISPOR Europe 2025
-
November 9: Prompt Engineering for HEOR: Practical Skills and Use Cases for HEOR Professionals - In Person at ISPOR Europe 2025
-
November 9: Using LLMs to Simplify Real-World Evidence Research - In Person at ISPOR Europe 2025
-
November 9: Budget Impact Analysis II: Practical Steps to Building a BIA and Enhanced Applications - In Person at ISPOR Europe 2025
-
November 9: Valuation of Innovative Drugs - In Person at ISPOR Europe 2025
-
November 9: Causal Inference and Causal Estimands From Target Trial Emulations Using Evidence From Real-World Observational Studies and Clinical Trials - In Person at ISPOR Europe 2025
-
HEOR Meets Investing—Why Are Banks and VCs Collaborating With Health Economists?
-
December 3-4: Applying RWD and Novel Data Sources to Advance Patient-Centric Health Equity, Outcomes, and Economic Evaluations - Virtual
-
The Application of AI in COA Research: Opportunities and Challenges
-
February 11-12: Estimating Health-State Utility for Economic Models in Clinical Trials and Real-World Studies - Virtual
-
February 18-19: Introduction to Health Technology Assessment - Virtual
-
February 25-26: Navigating Pharmaceutical Market Access in the EU: Harnessing Evidence, Creating Value and Collaborating for Success - Virtual
-
March 25: Primer on a 6-Step Approach to Budget Impact Analysis - Virtual
-
Defining Value Upstream: A Canadian Success Story in Early Modeling
-
April 22-23: Early Health Technology Assessment - Virtual
